Navigation Links
Drug Could Raise Risk of Heart Attack Among Type 2 Diabetes Patients
Date:9/18/2013

Pomona, CA (PRWEB) September 18, 2013

College of Pharmacy assistant professor Olivia J. Phung, PharmD, has published an article proposing that using a certain class of diabetes medication could potentially increase risk of heart attack and other cardiovascular problems.

The article, published in the journal Diabetic Medicine on Sept. 16, 2013, was a meta-analysis combining evidence from 33 studies to show an association with increased cardiovascular events when using this class of drug.

Phung and her WesternU team were funded by Merck to evaluate long-term use of sulfonylureas, a group of drugs that lower the amount of glucose in blood, and to find evidence behind the warnings on package insert labels that say that there is an increase in cardiovascular occurrences with these drugs.

“These results show that there is evidence of a potential association of this drug and potential harm to the patient with increased cardiovascular events,” said Phung. “It’s important for clinicians to be familiar with this so that they can be aware of the potential benefits and harms when prescribing these drugs.”

The finding warrants consideration in clinical practice when other treatment options may be available, Phung said.

“Diabetes itself is already a risk factor for increased cardiovascular events, so we don’t want to be adding to that,” Phung said.

The American Diabetes Association (ADA) recommends initial metformin as a drug therapy for most newly diagnosed Type 2 diabetes patients. Sulfonylureas remain one of the most commonly prescribed add-on therapies when treatment with metformin by itself is insufficient to reach recommended targets, Phung reported in her paper.

Phung said that the study does not provide enough evidence to show a direct cause-and-effect relationship. Rather, with these mostly observational studies, there is evidence of an association.

College of Pharmacy assistant professor Emmanuelle Schwartzman, PharmD, CDE, and Robert Allen, PharmD ’12, who was a fourth-year student at the time of the review, were key contributors to the study.

###

Western University of Health Sciences (http://www.westernu.edu), located in Pomona, Calif. and Lebanon, Ore., is an independent nonprofit health professions university, conferring degrees in biomedical sciences, dental medicine, health sciences, medical sciences, nursing, optometry, osteopathic medicine, pharmacy, physical therapy, physician assistant studies, podiatric medicine and veterinary medicine. The Chronicle of Higher Education named WesternU a Great College to Work For in 2012 and 2013.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11137368.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Red wine, fruit compound could help block fat cell formation
2. Pulse pressure elevation could presage cerebrovascular disease in Alzheimers patients
3. Report says new evidence could tip the balance in aspirin cancer prevention care
4. Climate Change Could Be Tough on Seniors Health: Study
5. Could Menthol Cigarettes Pose Even Higher Stroke Risk?
6. Online Tool Could Diagnose Autism Quickly, Developers Say
7. Codeine After Surgery Could Endanger Certain Kids: Study
8. BMC study shows diverting passengers to elevators could help reduce falls at Logan Airport
9. Discovery could help to develop drugs for organ transplant and cancer patients
10. Feelings of immaturity accompany alcohol misuse into adulthood; discovery could improve treatments
11. Saliva test could dramatically increase detection of oral cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... CA (PRWEB) , ... February 26, 2017 , ... NuevaCare, ... cities as diverse as Millbrae, Belmont, and Palo Alto, is proud to announce an ... Many Bay Area consumers look for home care close to home, and by having ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today it will ... the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace ... analytics to improve Medicaid population health management. , ODH will also have an exhibit ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... its newly designed TaskMate Go. Core benefits and advantages built into the home ... a stylish, functional look and feel. Ability to gain the benefits embedded in ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... ... February 24, 2017 , ... With millions ... so critically important that we all are aware of our options and are ... proud to announce the launch of its newest edition of "Vision and Hearing" ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017   Royal Philips ... a global leader in health technology, today announced ... Administration (FDA) to market its ElastQ Imaging capability, ... of ultrasound systems. ElastQ Imaging enables simultaneous imaging ... is essential for the diagnosis of various liver ...
(Date:2/27/2017)... --  Vitasome ® Labs , Inc. has launched ... new liposome technology. Whereas vitamins lose on average between ... Physician,s Desk Reference , Vitasome , s ® ... and are scientifically formulated to: ... Improve bioavailability with a vastly higher absorption rate ...
(Date:2/27/2017)... WASHINGTON, Pa. , Feb. 27, 2017  Impax Laboratories, Inc. (NASDAQ: ... following upcoming investor conferences. Raymond James ... ET on March 6, 2017 in Orlando, FL. ... Conference at 8:00 a.m. ET on March 7, 2017 in ... 8:30 a.m.ET on March 16, 2017 in Miami, FL. ...
Breaking Medicine Technology: